Antibody-Mediated-Rejection

New therapy to prevent Antibody-Mediated-Rejection (AMR) of kidney transplant

By Editor's Desk
31 May 2024

22 patients at the University Hospital Vienna and Charité –Universitätsmedizin Berlin who were diagnosed with antibody-mediated rejection (AMR) after a kidney transplant

Tag: Antibody-Mediated-Rejection

New therapy to prevent Antibody-Mediated-Rejection (AMR) of kidney transplant

Areas Covered

Discover More

Novartis Fabhalta Iptacopan FDA Approval Becomes First Complement Inhibitor to Slow Kidney Decline in Primary IgAN

LIPFENDRA FDA Approval: Merck’s Enlicitide Becomes First Oral PCSK9 Inhibitor to Lower LDL-C

GSK Nuvalent Acquisition: GSK Completes $10.6 Billion Nuvalent Acquisition, Expanding Lung Cancer Pipeline

Johnson & Johnson Q2 2026 Analysis: Company Reports $25.3 Billion in Sales, Raises Full-Year Outlook

Merck’s Erbitux BRAF V600E mCRC Regimen Gets EU Approval for First-Line Treatment

AstraZeneca Zegfrovy Deal: AstraZeneca Licenses Dizal’s Oral EGFR Inhibitor for Lung Cancer in Up to $1.5 Billion Agreement